Status:
WITHDRAWN
TM Meditation in Children With ADD/ADHD
Lead Sponsor:
Sheba Medical Center
Conditions:
Attention Deficit Disorder With Hyperactivity
Attention-Deficit Disorder in Adolescence
Eligibility:
All Genders
10-16 years
Brief Summary
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common developmental disorders experienced in childhood, with limited options for effective pharmacological treatment. Transcendental...
Detailed Description
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common developmental disorders experienced in childhood, with a prevalence of 5 -10%, and can persist into adulthood (1) It is charac...
Eligibility Criteria
Inclusion
- Children with a confirmed diagnosis of ADHD
Exclusion
- Comorbidities of Conduct Disorder, ODD, OCD
- Children on psychiatric medications
- Other chronic diseases
Key Trial Info
Start Date :
November 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 24 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03817593
Start Date
November 1 2021
End Date
May 24 2022
Last Update
May 31 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.